Stage II Breast Cancer Terminated Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00679029Combination Chemotherapy and Bevacizumab in Treating Women With HER2/Neu-Negative Stage II or Stage III Breast CancerTreatment
NCT00194792Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast CancerTreatment